Intel Corporation (INL.DE)
EUR 19.41
(-0.62%)
EUR 19.41
(-0.62%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 11.47 Billion | 15.43 Billion | 29.99 Billion | 35.38 Billion | 33.14 Billion | 29.43 Billion |
| Net Income | 1.67 Billion | 8.01 Billion | 19.86 Billion | 20.89 Billion | 21.04 Billion | 21.05 Billion |
| Depreciation & Amortization | 9.6 Billion | 13.03 Billion | 11.79 Billion | 12.23 Billion | 10.82 Billion | 9.08 Billion |
| Deferred income taxes | -42 Million | - | -1.45 Billion | - | - | -1.74 Billion |
| Stock-based compensation | 3.22 Billion | 3.12 Billion | 2.03 Billion | 1.85 Billion | 1.7 Billion | 1.54 Billion |
| Change in working capital | -2.56 Billion | -4.5 Billion | -4.87 Billion | 2.17 Billion | 1.14 Billion | -421 Million |
| Other non-cash items | -424 Million | -4.23 Billion | 2.62 Billion | -1.78 Billion | -1.58 Billion | -82 Million |
| Investing Cash Flow | -24.04 Billion | -10.47 Billion | -25.16 Billion | -20.79 Billion | -14.4 Billion | -11.23 Billion |
| Investments in PPE | -25.75 Billion | -25.05 Billion | -20.32 Billion | -14.45 Billion | -16.21 Billion | -15.18 Billion |
| Acquisitions | - | 6.57 Billion | -209 Million | -714 Million | -1.04 Billion | -516 Million |
| Investment purchases | -44.81 Billion | -44.15 Billion | -41.16 Billion | -29.95 Billion | -11.95 Billion | -13.34 Billion |
| Sales/Maturities of investments | 44.54 Billion | 53.69 Billion | 35.88 Billion | 23.06 Billion | 14.09 Billion | 18.07 Billion |
| Other Investing Activities | 1.97 Billion | -1.54 Billion | 658 Million | 1.26 Billion | 715 Million | -272 Million |
| Financing Cash Flow | 8.5 Billion | 1.36 Billion | -5.86 Billion | -12.91 Billion | -17.56 Billion | -18.6 Billion |
| Debt repayment | -4.46 Billion | -5.32 Billion | -2.5 Billion | -4.52 Billion | -2.62 Billion | -3.02 Billion |
| Dividends payments | -3.08 Billion | -5.99 Billion | -5.64 Billion | -5.56 Billion | -5.57 Billion | -5.54 Billion |
| Common Stock Repurchased | - | - | -2.41 Billion | -14.22 Billion | -13.57 Billion | -10.73 Billion |
| Common Stock Issuance | - | 1.03 Billion | 5.99 Billion | 11.14 Billion | 4.14 Billion | 1.43 Billion |
| Other Financing Activities | 16.05 Billion | 11.65 Billion | -1.29 Billion | 261 Million | 72 Million | -748 Million |
| Accounts receivables | 731 Million | 5.32 Billion | -2.67 Billion | 883 Million | -935 Million | -1.71 Billion |
| Accounts payables | -801 Million | -29 Million | 1.19 Billion | 412 Million | 696 Million | 211 Million |
| Inventory | 2.09 Billion | -2.43 Billion | -2.33 Billion | -687 Million | -1.48 Billion | -214 Million |
| Other working capital | -4.59 Billion | -7.37 Billion | -1.05 Billion | 1.57 Billion | 2.86 Billion | 1.29 Billion |
| Cash at beginning of period | 11.14 Billion | 4.82 Billion | 5.86 Billion | 4.19 Billion | 3.01 Billion | 3.43 Billion |
| Cash at end of period | 7.07 Billion | 11.14 Billion | 4.82 Billion | 5.86 Billion | 4.19 Billion | 3.01 Billion |
| Capital Expenditure | -25.75 Billion | -25.05 Billion | -20.32 Billion | -14.45 Billion | -16.21 Billion | -15.18 Billion |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -4.06 Billion | 6.31 Billion | -1.03 Billion | 1.67 Billion | 1.17 Billion | -414 Million |
| Free Cash Flow | -14.27 Billion | -9.61 Billion | 9.66 Billion | 20.93 Billion | 16.93 Billion | 14.25 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.65 Billion | -437 Million | 1.67 Billion | 2.66 Billion | 310 Million | 1.47 Billion |
| Depreciation & Amortization | 2.56 Billion | 2.55 Billion | 9.6 Billion | 2.51 Billion | 2.44 Billion | 2.27 Billion |
| Deferred income taxes | - | - | -42 Million | -89 Million | 193 Million | 21 Million |
| Stock-based compensation | 780 Million | 1.17 Billion | 3.22 Billion | 796 Million | 772 Million | 922 Million |
| Change in working capital | -470 Million | -4.65 Billion | -2.56 Billion | -114 Million | 1.63 Billion | -2.08 Billion |
| Other non-cash items | 943 Million | 348 Million | -424 Million | -1.14 Billion | 463 Million | 200 Million |
| Investing Cash Flow | -9.16 Billion | -2.56 Billion | -24.04 Billion | -5.31 Billion | -7.39 Billion | -2.8 Billion |
| Investments in PPE | -5.68 Billion | -5.97 Billion | -25.75 Billion | -6.69 Billion | -5.75 Billion | -5.88 Billion |
| Acquisitions | - | - | - | -375 Million | 122 Million | 253 Million |
| Investment purchases | -11.17 Billion | -6.46 Billion | -44.81 Billion | -7.52 Billion | -11.59 Billion | -9.56 Billion |
| Sales/Maturities of investments | 7.61 Billion | 9.59 Billion | 44.54 Billion | 7.82 Billion | 9.76 Billion | 12.66 Billion |
| Other Investing Activities | 75 Million | 269 Million | 1.97 Billion | 1.45 Billion | 60 Million | -277 Million |
| Financing Cash Flow | 11.23 Billion | 3.63 Billion | 8.5 Billion | 152 Million | 842 Million | 117 Million |
| Debt repayment | -552 Million | -3.33 Billion | -4.46 Billion | - | -423 Million | -1.09 Billion |
| Dividends payments | -534 Million | -529 Million | -3.08 Billion | -527 Million | -525 Million | -524 Million |
| Common Stock Repurchased | - | - | - | - | - | -659 Million |
| Common Stock Issuance | - | - | - | - | - | 659 Million |
| Other Financing Activities | 11.21 Billion | 203 Million | 16.05 Billion | 679 Million | 1.79 Billion | 1.73 Billion |
| Accounts receivables | 192 Million | 80 Million | 731 Million | -559 Million | 153 Million | 851 Million |
| Accounts payables | 570 Million | -386 Million | -801 Million | 281 Million | 20 Million | -331 Million |
| Inventory | 250 Million | -366 Million | 2.09 Billion | 339 Million | 518 Million | 1 Billion |
| Other working capital | -2.05 Billion | -2.1 Billion | -4.59 Billion | -175 Million | 948 Million | -3.61 Billion |
| Cash at beginning of period | 6.92 Billion | 7.07 Billion | 11.14 Billion | 7.62 Billion | 8.34 Billion | 8.23 Billion |
| Cash at end of period | 11.28 Billion | 6.92 Billion | 7.07 Billion | 7.07 Billion | 7.62 Billion | 8.34 Billion |
| Capital Expenditure | -5.68 Billion | -5.97 Billion | -25.75 Billion | -6.69 Billion | -5.75 Billion | -5.88 Billion |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 4.36 Billion | -156 Million | -4.06 Billion | -542 Million | -728 Million | 117 Million |
| Free Cash Flow | -3.39 Billion | -7.19 Billion | -14.27 Billion | -2.07 Billion | 71 Million | -3.08 Billion |
SOLB
SMSPHARMA
002255
000953
NOKBF
FCAP